Description
Coronavirus SeroAssay
Benefits
- 2 hours from samples to result. 30 minutes hands on time
- Multiplexed analysis of current and past endemic strains
- 100% Clinical Specificity and and 98.5% Clinical Sensitivity
- Compatible with recombinant, peptide, VLP and other advanced vaccine technologies.
Applications
- Evaluate serological samples from preclinical and clinical studies
- Screen immunological profile of study participants against all human coronaviruses
- Quantify vaccine immunogenicity
- Confirm cross protection against 7 different coronaviruses
- Research population level seroprevalence
